doi: 10.1161/hc2901.091399
(Circulation. 2001;104:448.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice
From the Cardiovascular Research Center, Cardiology Division, and Department of Pathology (T.H.A.), Massachusetts General Hospital, and Harvard Medical School, Boston, Mass.
Correspondence to Paul L. Huang, MD, PhD, Cardiovascular Research Center, Massachusetts General Hospital East, 149 E 13th St, Charlestown, MA 02129. E-mail huangp{at}helix.mgh.harvard.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— To test whether deficiency in endothelial nitric oxide synthase (eNOS) affects atherosclerosis development, we compared lesion formation in apolipoprotein E (apoE)/eNOS-double knockout (DKO) and apoE-knockout (KO) control animals.
Methods and Results— After 16 weeks of "Western-type" diet, apoE/eNOS-DKO males and females showed significant increases in lesion area of 93.6% and 59.2% compared with apoE-KO mice. All apoE/eNOS-DKO animals studied developed peripheral coronary arteriosclerosis, associated with perivascular and myocardial fibrosis, whereas none of the apoE-KO mice did. Transthoracic echocardiography showed a significantly increased left ventricular wall thickness and decreased fractional shortening in DKO animals. Mean arterial pressure was increased in DKO mice and was comparable in degree to eNOS-KO animals. Male DKO animals developed atherosclerotic abdominal aneurysms and aortic dissection.
Conclusions— eNOS deficiency increases atherosclerosis in Western-type diet-fed apoE-KO animals and introduces coronary disease and an array of cardiovascular complications, including spontaneous aortic aneurysm and dissection. This phenotype constitutes the first murine model to demonstrate distal coronary arteriosclerosis associated with evidence of myocardial ischemia, infarction, and heart failure. Hypertrophy and reduced left ventricular function cannot be explained by increased blood pressure alone, because eNOS-KO animals do not develop these complications.
Key Words: arteriosclerosis • nitric oxide synthase • coronary disease • aneurysm • hypertension
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Nitric oxide (NO) plays important roles in endothelium-dependent vasodilation.1–3 It is released by the vascular endothelium in response to various stimuli, including acetylcholine and blood flow. Diseased segments of coronary arteries constrict, rather than dilate, in response to the endothelium-dependent vasodilator acetylcholine, a phenomenon called endothelial dysfunction.4 The molecular mechanisms responsible may lie in substrate (L-arginine) or cofactor (tetrahydrobiopterin) deficiency for nitric oxide synthases (NOS), alterations in membrane signaling, or enhanced degradation of NO.5,6 Aside from effects on vascular tone, NO has physiological properties that may be antiatherogenic, including inhibition of smooth muscle cell proliferation, platelet aggregation and adhesion, and leukocyte activation and adhesion.7–10 NO may serve as an oxidant, however, as well as an antioxidant.11 Under certain conditions of substrate and cofactor deficiency, NOS enzymes can produce superoxide rather than NO.12,13 In human atherosclerotic plaques, all 3 isoforms, neuronal (nNOS), inducible (iNOS), and endothelial (eNOS), are present.14 Although most experimental data support a protective role of eNOS, the precise roles of nNOS, iNOS, and eNOS in lesion formation have not been proved.
Atherosclerotic lesions do not develop at random locations throughout the vasculature but rather occur in areas of predilection, such as areas of curvature or branch vessels with nonlaminar flow.15,16 The eNOS gene is regulated acutely by shear force through changes in enzyme activity and chronically by changes in gene expression. Local changes in eNOS expression or activity have been proposed to target lesion development to areas of predilection.17,18
To study the contribution of eNOS to lesion formation, we combined a genetic model of eNOS deficiency with a mouse model of atherosclerosis, the hyperlipidemic apolipoprotein E-knockout (apoE-KO) mouse. Unlike most mouse strains, which are highly resistant to atherosclerosis, apoE-KO mice develop atherosclerotic lesions in a distribution closely resembling human disease.19 Disease progression can be substantially accelerated by a "Western-type" atherogenic diet. By breeding eNOS-knockout (eNOS-KO) mice with apoE-KO mice, we bypassed problems due to lack of specificity of NOS inhibitors. To avoid genetic background effects, we used highly inbred animals, all backcrossed for 10 generations to the C57BL/6 strain.
In the present study, we show that chronic deficiency of eNOS increases atherosclerosis in the Western-type diet-fed apoE-KO mouse model. Furthermore, in the absence of eNOS, peripheral coronary disease, chronic myocardial ischemia, heart failure, and an array of vascular complications develop that have not been observed in apoE-KO animals.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Mice
All mice were backcrossed for 10 generations to the C57BL/6J genetic background. eNOS-KO mice20 and apoE-KO mice21 (Jackson Laboratories, Bar Harbor, Me) were crossed to generate double heterozygous mice. These mice were then crossed and the offspring genotyped for eNOS by Southern blotting20 and for apoE by polymerase chain reaction. ApoE-KO animals that were wild-type, heterozygous, or knockout for eNOS were weaned at 21 days and fed a Western-type diet (42% of total calories from fat; 0.15% cholesterol; Harlan-Teklad) for 16 or 24 weeks.
Lesion Assessment
Animals were anesthetized (80 g/mL pentobarbital IP) and perfused with PBS, pH 7.4, and the aorta was dissected from the aortic valve to the iliac bifurcation and fixed in 4% paraformaldehyde overnight.22 The vessel was opened longitudinally and pinned onto a black wax surface. Serial images were captured with a video camera mounted on a stereo microscope. To identify lipid-rich intraluminal lesions, the aortas were stained with Sudan IV. Color photographs were taken with a Leitz 35-mm camera and used as a reference to identify lesions on the video images. Image analysis was performed with Image Pro Plus (Version 3.0.1; Media Cybernetics). The amount of lesion formation in each animal was expressed as percent lesion area per total area of the aorta.
Tissue Preparation and Histology
The left ventricle (LV) was cannulated, and the animals were perfused with 0.9% NaCl followed by 10% phosphate-buffered formalin. The heart was embedded in paraffin, and serial 5-µm sections were taken in the midventricular short axis and through the aortic valve. Sections were stained with hematoxylin/eosin or Masson’s trichrome. Aortic aneurysms were evaluated according to the Society for Vascular Surgery, International Society for Cardiovascular Surgery. The size of the abdominal aortic aneurysm was calculated from the circumference of the luminal surface (diameter=luminal circumference/
), compared with the circumference of the adjacent, undilated, proximal aortic segment. Aneurysms were defined as an increase in vessel diameter of >50%.
Lipids and Lipoprotein Characterization
Animals were fasted for 4 hours, and plasma total cholesterol was measured with reagents from Sigma (kit 352). Lipoprotein cholesterol distribution was evaluated after fractionation by fast protein liquid chromatography (FPLC) gel filtration with a Superose 6 column.
Blood Pressure Measurements
Invasive blood pressure was measured as previously reported from our laboratory.23
Echocardiography
Mice were lightly sedated (20 mg/kg pentobarbital IP) and secured to an imaging platform. M-mode and 2D echocardiographic images were obtained.24 Measurements were taken from the 2D pictures, and M-mode images served as a reference. Heart rate was measured from the cycle length on the M-mode echocardiograms. Fractional shortening <30% was taken as evidence for impaired LV systolic function.
Statistical Analysis
Statistical analysis was performed with StatView 4.51 (Abacus Concepts, Inc). Two-way ANOVA was used for repeated measures, followed by Scheffé’s F test. A probability value of P<0.05 was considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The total area of the aorta, total cholesterol, and lipoprotein profile by FPLC did not differ between apoE-KO mice and apoE/eNOS-DKO mice fed the Western-type diet for 16 weeks. Body weight did not differ between genotypes among animals of the same sex. Table 1 shows some hemodynamic characteristics of the animals studied. The mean arterial pressure of apoE/eNOS-DKO animals was elevated by 25 mm Hg compared with apoE-KO control animals and was similar to the blood pressure of eNOS-KO animals.20 ApoE-KO animals also had a significantly elevated mean arterial pressure compared with age-matched C57BL6 mice, but the elevation was less marked than in apoE/eNOS-DKO mice. Mean heart rate did not differ between apoE/eNOS-DKO, apoE-KO, and C57BL6 animals.
|
Inspection of the longitudinally opened vessels revealed that apoE/eNOS-DKO and apoE-KO control animals develop aortic atherosclerotic lesions in the same areas of predilection, namely, at sites of branch vessels or curvature (Figure 1). After 16 weeks on a Western-type diet, apoE/eNOS-DKO males showed an increase in lesion area of 93.6% compared with apoE-KO males, and females showed an increase of 59.2% compared with apoE-KO females (Figure 2). Consistent with the reports of Caligiuri et al,25 female apoE-KO control animals had significantly greater lesion areas at the 4-month time point than male apoE-KO animals. This difference at 4 months was not present between female and male apoE/eNOS-DKO animals. ApoE-KO males and females heterozygous for eNOS showed lesion areas that were not significantly different from those of apoE-KO animals (data not shown).
|
|
0.05).Of 12 male apoE/eNOS-DKO animals that were on the Western-type diet for 16 weeks, 3 developed abdominal aortic aneurysms, with a maximal increase in vessel diameter of 180% (Figure 3a). The aneurysms were classified as atherosclerotic suprarenal abdominal aneurysms. Two additional male apoE/eNOS-DKO mice developed acute Stanford type B aortic dissections (Figure 3b). Figure 4 shows the histology of an aortic dissection, with a clearly defined true lumen and false lumen, and atherosclerotic lesions within the true lumen. Neither we nor others have observed macroscopic aortic aneurysms or aortic dissections in apoE-KO mice, regardless of diet.
|
|
In a second set of experiments, apoE-KO animals were fed the Western-type diet for 24 weeks to determine whether vascular complications seen in DKO animals at 16 weeks would develop in apoE-KO animals, only later. None of the analyzed apoE-KO animals (n=17) developed macroscopic aneurysms or dissection. Aortic lesion area increased in apoE-KO animals fed a Western-type diet for 6 months (males: mean area 31.3±1.6%, n=11; females: mean area 32.1±3.3%, n=6). These values are comparable to those in apoE/eNOS-DKO animals at 16 weeks. Furthermore, like the apoE/eNOS-DKO animals, the lesion areas did not differ between male and female animals.
Histological evaluation of cross sections through the midventricular short axis of the hearts of DKO animals revealed distal coronary arteriosclerosis in all apoE/eNOS-DKO animals studied (n=10), regardless of sex. Coronary arteriosclerosis was associated with perivascular (Figure 5F and 5G) and endomyocardial (Figure 5E) fibrosis and endomyocardial scars consistent with nontransmural infarction (Figure 5H and 5I). Neither distal coronary disease nor fibrosis was seen in apoE-KO control animals (n=7).
|
To evaluate whether these histological findings coincide with impaired cardiac function, we studied a separate set of apoE/eNOS-DKO and apoE-KO control animals fed a Western-type diet for 16 weeks by transthoracic echocardiography (Table 2). ApoE/eNOS-DKO animals showed a significant increase in the thickness of the interventricular septum and the posterior wall compared with apoE-KO, eNOS-KO, or C57BL6 control animals. Moreover, DKO animals displayed a decrease in fractional shortening. Two of 10 DKO animals displayed massive LV dilation (Figure 6C), with a reduction in fractional shortening to <30%. LV wall thickness and fractional shortening did not differ between age-matched apoE-KO, C57BL6, and eNOS-KO animals.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Atherosclerotic lesions develop as a result of chronic inflammation of the vessel wall, orchestrated by the interaction of endothelium, monocytes, T lymphocytes, smooth muscle cells, and fibroblasts.26 eNOS, expressed in the endothelial layer, is strategically positioned to affect luminal and abluminal processes. Ample evidence suggests that it plays a protective role. To test the hypothesis that eNOS deficiency, a hallmark of endothelial dysfunction, affects the development of atherosclerosis, we compared lesion formation in apoE-KO mice and apoE/eNOS-DKO mice after 16 weeks of Western-type diet.
We found that genetic deficiency of eNOS significantly increases atherosclerosis in the Western-type diet-fed apoE-KO mouse model. The location of the lesions was similar in apoE/eNOS-DKO mice to that in apoE-KO mice. Aortic lesions still developed in areas of predilection with disturbed flow characteristics. Thus, absence of eNOS does not initiate or determine the site of lesion formation in the aorta but appears to accelerate its development.
The apoE/eNOS-DKO mice showed evidence of peripheral coronary disease, chronic myocardial ischemia, and impaired LV function. Nakashima et al19 reported that apoE-KO mice fed a Western-type diet for >20 weeks develop coronary lesions, but these progress from aortic root lesions and are limited to the proximal coronary arteries. To the best of our knowledge, no studies have found distal coronary lesions in mouse models of atherosclerosis. We found both proximal and distal coronary arteriosclerosis in apoE/eNOS-DKO animals. The lesions were associated with perivascular and endomyocardial fibrosis, suggestive of chronic hypoxic stress, and myocardial scars, consistent with myocardial infarction. We did not detect coronary arteriosclerosis in any of the apoE-KO animals. Transthoracic echocardiography revealed that apoE/eNOS-DKO animals had globally impaired systolic function and significant reduction in fractional shortening. This was associated with an increase in LV end systolic diameter. Furthermore, the DKO animals developed concentric LV hypertrophy. Neither hypertrophy nor dilation was found either in age-matched apoE-KO animals or in eNOS-KO animals.
Five of 12 male apoE/eNOS-DKO animals developed peripheral vascular complications of aortic dissection and aortic aneurysm. Aneurysm formation is thought to occur by weakening of the elastic laminae in the media by matrix metalloproteinases and/or other proteases. Microscopic aneurysm formation and medial elastin destruction have been observed after a diet containing the toxic component cholic acid in apoE-KO mice27 and LDL receptor-KO mice.28 Aneurysms have also been induced in wild-type mice by perfusing the aorta with elastase.29 Spontaneous aortic dissection and macroscopic aneurysm formation, however, have not been reported in mouse models of atherosclerosis. The addition of eNOS deficiency to the Western-type diet-fed apoE-KO mouse model results in the development of aneurysm and aortic dissection without the additional injury of cholic acid or elastase treatment.
The sex difference between males and females at 16 weeks of Western-type diet in apoE-KO mice is no longer seen at 24 weeks, suggesting that the rate, not the ultimate extent, of lesion formation is greater in female apoE-KO mice. Lesion areas in the apoE/eNOS-DKO mice fed for 16 weeks were comparable to those of apoE-KO mice fed for 24 weeks, and no differences were noted between male and female DKO mice. Despite equivalent lesion burdens, apoE-KO mice fed for 24 weeks did not show coronary arteriosclerosis, aortic aneurysm, or dissection. Although coronary disease was present in all the apoE/eNOS-DKO mice studied, female DKO mice did not develop aneurysms or aortic dissection. The reasons for this are unclear, because female DKO mice have comparable lesion burdens and blood pressure elevations.
Our results differ from those of Knowles et al,30 who also found increased atherosclerosis in apoE/eNOS-DKO mice, using a different eNOS-KO mouse for the generation of the DKO animals. These authors did not find distal coronary lesions, myocardial ischemia, heart failure, or vascular complications of aortic aneurysm and aortic dissection. There are several important differences between their study and ours. First, all of our animals were backcrossed to a C57BL/6 background, so we have eliminated genetic background as a possible confounder. Second, we used a Western-type diet rather than normal chow diet, which accelerates the progression of atherosclerotic lesions.
Hypertension may certainly play a role in the development of atherosclerosis and its cardiac and vascular complications. ApoE-KO animals progressively develop endothelial dysfunction and hypertension.31,32 We found that apoE-KO animals had higher blood pressure than C57BL6 control animals. ApoE/eNOS-DKO animals, however, showed a more marked increase in blood pressure, comparable to that of eNOS-KO mice.23 This indicates that the blood pressure effects of apoE gene deficiency and eNOS gene deficiency are not additive but rather reflect different degrees of endothelial dysfunction. Furthermore, hypertension alone cannot account for the cardiac hypertrophy, impaired contractility, or vascular complications seen in the apoE/eNOS-DKO mice, because these complications do not occur in eNOS-KO mice. ApoE-KO animals heterozygous for eNOS did not show an increase in lesion formation or an increase in blood pressure compared with apoE-KO control animals, suggesting a threshold, rather than a gene-dose, effect of eNOS deficiency on both parameters.
The mechanisms by which hypertension contributes to atherosclerosis have not been fully elucidated. Inasmuch as eNOS plays important roles in recruitment of inflammatory cells, oxidative stress, and vascular response to injury, eNOS deficiency/endothelial dysfunction could be one of the molecular mechanisms linking hypertension to atherosclerosis. Knowles et al30 attempted to separate the effects of hypertension from those of NO deficiency by administering the ACE inhibitor enalapril to their apoE/eNOS-DKO mice. Enalapril corrects both the hypertension and the enhanced atherosclerosis, but this may be because ACE itself and its products, angiotensin II and bradykinin, play important roles in atherogenesis.33,34
In summary, eNOS deficiency changes the disease pattern of atherosclerosis in Western-type diet-fed apoE-KO animals, introducing peripheral coronary disease, signs of chronic myocardial ischemia, and vascular complications, such as aortic dissection and abdominal aortic aneurysm formation. The phenotype of apoE/eNOS-DKO mice more closely resembles the spectrum of cardiovascular complications seen in human atherosclerosis and constitutes the first murine model to demonstrate spontaneous distal coronary arteriosclerosis associated with LV dysfunction. These findings support the concept that restoration of eNOS function in patients with atherosclerosis is an important therapeutic goal.
|
Acknowledgments |
|---|
This work was supported by NINDS grant NS-33335 and NHLBI grant HL-52818 to Dr Huang. Dr Huang is an Established Investigator of the American Heart Association.
Received February 15, 2001; revision received March 28, 2001; accepted March 30, 2001.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Ignarro LJ, Byrns RE, Buga GM, et al. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther. 1988; 244: 181–189.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288: 373–376.[Medline] [Order article via Infotrieve]
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43: 109–142.[Medline] [Order article via Infotrieve]
4. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986; 315: 1046–1051.[Abstract]
5. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993; 91: 2546–2551.
6.
Xia Y, Tsai AL, Berka V, et al. Superoxide generation from endothelial nitric-oxide synthase: a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998; 273: 25804–25808.
7. Bath PM. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur J Clin Pharmacol. 1993; 45: 53–58.[Medline] [Order article via Infotrieve]
8. Lefer AM, Ma XL, Weyrich A, et al. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl. 1993; 41: 127–135.[Medline] [Order article via Infotrieve]
9. Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol. 1995; 25: 674–678.[Medline] [Order article via Infotrieve]
10. Radomski MW, Palmer RM, Moncada S. Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol Sci. 1991; 12: 87–88.[Medline] [Order article via Infotrieve]
11.
Goss SP, Hogg N, Kalyanaraman B. The effect of nitric oxide release rates on the oxidation of human low density lipoprotein. J Biol Chem. 1997; 272: 21647–21653.
12.
Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A. 1998; 95: 9220–9225.
13.
Wang W, Wang S, Yan L, et al. Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J Biol Chem. 2000; 275: 16899–16903.
14.
Wilcox JN, Subramanian RR, Sundell CL, et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997; 17: 2479–2488.
15. Giddens DP, Zarins CK, Glagov S. The role of fluid mechanics in the localization and detection of atherosclerosis. J Biomech Eng. 1993; 115: 588–594.[Medline] [Order article via Infotrieve]
16. Nerem RM. Vascular fluid mechanics, the arterial wall, and atherosclerosis. J Biomech Eng. 1992; 114: 274–282.[Medline] [Order article via Infotrieve]
17.
Topper JN, Cai J, Falb D, et al. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A. 1996; 93: 10417–10422.
18.
Gimbrone MA Jr. Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol. 1999; 155: 1–5.
19.
Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994; 14: 133–140.
20. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995; 377: 239–242.[Medline] [Order article via Infotrieve]
21.
Piedrahita JA, Zhang SH, Hagaman JR, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992; 89: 4471–4475.
22.
Palinski W, Ord VA, Plump AS, et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994; 14: 605–616.
23. Gyurko R, Kuhlencordt P, Fishman MC, et al. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol. 2000; 278: H971–981.
24.
Scherrer-Crosbie M, Steudel W, Ullrich R, et al. Echocardiographic determination of risk area size in a murine model of myocardial ischemia. Am J Physiol. 1999; 277: H986–H992.
25. Caligiuri G, Nicoletti A, Zhou X, et al. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. 1999; 145: 301–308.[Medline] [Order article via Infotrieve]
26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801–809.[Medline] [Order article via Infotrieve]
27. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997; 17: 439–444.[Medline] [Order article via Infotrieve]
28. Prescott MF, Sawyer WK, Von Linden-Reed J, et al. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci. 1999; 878: 179–190.[Medline] [Order article via Infotrieve]
29. Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000; 105: 1641–1649.[Medline] [Order article via Infotrieve]
30. Knowles JW, Reddick RL, Jennette JC, et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)ApoE(-/-) mice are ameliorated by enalapril treatment. J Clin Invest. 2000; 105: 451–458.[Medline] [Order article via Infotrieve]
31.
Yang R, Powell-Braxton L, Ogaoawara AK, et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 1999; 19: 2762–2768.
32.
Williams KJ, Scalia R, Mazany KD, et al. Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol. 2000; 20: 1033–1039.
33. Morishita R, Gibbons GH, Ellison KE, et al. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994; 94: 978–984.
34. Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens Suppl. 1994; 12: S3–S10.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  Z. T. Bloomgarden Incretin Concepts Diabetes Care, February 1, 2010; 33(2): e20 - e25. [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Judkins, H. Diep, B. R. S. Broughton, A. E. Mast, E. U. Hooker, A. A. Miller, S. Selemidis, G. J. Dusting, C. G. Sobey, and G. R. Drummond Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice Am J Physiol Heart Circ Physiol, January 1, 2010; 298(1): H24 - H32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Qian, Q. Zhang, J. E. Church, D. W. Stepp, R. D. Rudic, and D. J. R. Fulton Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation Am J Physiol Heart Circ Physiol, January 1, 2010; 298(1): H112 - H118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sartori, P. Dessen, C. Mathieu, A. Monney, J. Bloch, P. Nicod, U. Scherrer, and H. Duplain Melatonin Improves Glucose Homeostasis and Endothelial Vascular Function in High-Fat Diet-Fed Insulin-Resistant Mice Endocrinology, December 1, 2009; 150(12): 5311 - 5317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Daum, A. Grabski, and M.A. Reidy Sphingosine 1-Phosphate: A Regulator of Arterial Lesions Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1439 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bousette, P. D'Orleans-Juste, R. S. Kiss, Z. You, J. Genest, W. Al-Ramli, S. T. Qureshi, A. Gramolini, D. Behm, E. H. Ohlstein, et al. Urotensin II Receptor Knockout Mice on an ApoE Knockout Background Fed a High-Fat Diet Exhibit an Enhanced Hyperlipidemic and Atherosclerotic Phenotype Circ. Res., September 25, 2009; 105(7): 686 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Alexander, S. Poloyac, L. Hoffman, M. Gallek, Dianxu Ren, J. Balzer, A. Kassam, and Y. Conley Endothelial Nitric Oxide Synthase Tagging Single Nucleotide Polymorphisms and Recovery From Aneurysmal Subarachnoid Hemorrhage Biol Res Nurs, July 1, 2009; 11(1): 42 - 52. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Ganz, J. E. Ho, and P. Y. Hsue Structural and functional manifestations of human atherosclerosis: do they run in parallel? Eur. Heart J., July 1, 2009; 30(13): 1556 - 1558. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ponnuswamy, E. Ostermeier, A. Schrottle, J. Chen, P. L. Huang, G. Ertl, B. Nieswandt, and P. J. Kuhlencordt Oxidative Stress and Compartment of Gene Expression Determine Proatherosclerotic Effects of Inducible Nitric Oxide Synthase Am. J. Pathol., June 1, 2009; 174(6): 2400 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Balligand, O. Feron, and C. Dessy eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues Physiol Rev, April 1, 2009; 89(2): 481 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Steffel and T. F. Luscher Predicting the Development of Atherosclerosis Circulation, February 24, 2009; 119(7): 919 - 921. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Moukdar, J. Robidoux, O. Lyght, J. Pi, K. W. Daniel, and S. Collins Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice J. Lipid Res., January 1, 2009; 50(1): 59 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tarin, M. Gomez, E. Calvo, J. A. Lopez, and C. Zaragoza Endothelial Nitric Oxide Deficiency Reduces MMP-13-Mediated Cleavage of ICAM-1 in Vascular Endothelium: A Role in Atherosclerosis Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 27 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lukowski, P. Weinmeister, D. Bernhard, S. Feil, M. Gotthardt, J. Herz, S. Massberg, A. Zernecke, C. Weber, F. Hofmann, et al. Role of Smooth Muscle cGMP/cGKI Signaling in Murine Vascular Restenosis Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1244 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Wohlfart, H. Xu, A. Endlich, A. Habermeier, E. I. Closs, T. Hubschle, C. Mang, H. Strobel, T. Suzuki, H. Kleinert, et al. Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 370 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Vasdekis, M. Argentou, J. D. Kakisis, A. Bossios, D. Gourgiotis, M. Karanikolas, and G. Karatzas A Global Assessment of the Inflammatory Response Elicited Upon Open Abdominal Aortic Aneurysm Repair Vascular and Endovascular Surgery, March 1, 2008; 42(1): 47 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 V. W.T. Liu and P. L. Huang Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice Cardiovasc Res, January 1, 2008; 77(1): 19 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Hastings, M. B. Simmers, O. G. McDonald, B. R. Wamhoff, and B. R. Blackman Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1824 - C1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Welch, Y. Sun, B. J. Arey, V. Lemaitre, N. Sharma, M. Ishibashi, S. Sayers, R. Li, A. Gorelik, N. Pleskac, et al. Spontaneous Atherothrombosis and Medial Degradation in Apoe-/-, Npc1-/- Mice Circulation, November 20, 2007; 116(21): 2444 - 2452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Won, S.-N. Zhu, M. Chen, A.-M. Teichert, J. E. Fish, C. C. Matouk, M. Bonert, M. Ojha, P. A. Marsden, and M. I. Cybulsky Relative Reduction of Endothelial Nitric-Oxide Synthase Expression and Transcription in Atherosclerosis-Prone Regions of the Mouse Aorta and in an in Vitro Model of Disturbed Flow Am. J. Pathol., November 1, 2007; 171(5): 1691 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Steinkamp-Fenske, L. Bollinger, H. Xu, Y. Yao, S. Horke, U. Forstermann, and H. Li Reciprocal Regulation of Endothelial Nitric-Oxide Synthase and NADPH Oxidase by Betulinic Acid in Human Endothelial Cells J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takaya, K.-i. Hirata, T. Yamashita, M. Shinohara, N. Sasaki, N. Inoue, T. Yada, M. Goto, A. Fukatsu, T. Hayashi, et al. A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1632 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hamik, Z. Lin, A. Kumar, M. Balcells, S. Sinha, J. Katz, M. W. Feinberg, R. E. Gerszten, E. R. Edelman, and M. K. Jain Kruppel-like Factor 4 Regulates Endothelial Inflammation J. Biol. Chem., May 4, 2007; 282(18): 13769 - 13779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Davidson and M. R. Duchen Endothelial Mitochondria: Contributing to Vascular Function and Disease Circ. Res., April 27, 2007; 100(8): 1128 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Aicher, C. Urbich, A. Zeiher, S. Dimmeler, and H.-J. Schafers Endothelial Nitric Oxide Synthase in Bicuspid Aortic Valve Disease Ann. Thorac. Surg., April 1, 2007; 83(4): 1290 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Madamanchi and M. S. Runge Mitochondrial Dysfunction in Atherosclerosis Circ. Res., March 2, 2007; 100(4): 460 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lowenstein Beneficial Effects of Neuronal Nitric Oxide Synthase in Atherosclerosis Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1417 - 1418. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, R. Lopez-Ridaura, D. J. Hunter, N. Rifai, and F. B. Hu Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among u.s. Diabetic men. Diabetes, July 1, 2006; 55(7): 2140 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Kuhlencordt, S. Hotten, J. Schodel, S. Rutzel, K. Hu, J. Widder, A. Marx, P. L. Huang, and G. Ertl Atheroprotective Effects of Neuronal Nitric Oxide Synthase in Apolipoprotein E Knockout Mice Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, K. Witte, M. August, I. Brausch, U. Godtel-Armbrust, A. Habermeier, E. I. Closs, M. Oelze, T. Munzel, and U. Forstermann Reversal of Endothelial Nitric Oxide Synthase Uncoupling and Up-Regulation of Endothelial Nitric Oxide Synthase Expression Lowers Blood Pressure in Hypertensive Rats J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2536 - 2544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Moncada Adventures in vascular biology: a tale of two mediators Phil Trans R Soc B, May 29, 2006; 361(1469): 735 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zaheer, M. Murshed, A. M. De Grand, T. G. Morgan, G. Karsenty, and J. V. Frangioni Optical Imaging of Hydroxyapatite in the Calcified Vasculature of Transgenic Animals Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1132 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, J. E. Church, D. Jagnandan, J. D. Catravas, W. C. Sessa, and D. Fulton Functional Relevance of Golgi- and Plasma Membrane-Localized Endothelial NO Synthase in Reconstituted Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1015 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang and X.-F. Ming Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res., March 1, 2006; 4(1): 53 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mitsias, N. Ramadan, S. Levine, L Schultz, and K. Welch Factors Determining Headache at Onset of Acute Ischemic Stroke Cephalalgia, February 1, 2006; 26(2): 150 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion Physiol Rev, January 1, 2006; 86(1): 1 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Mehra, V. S. Ramgolam, and J. R. Bender Cytokines and cardiovascular disease J. Leukoc. Biol., October 1, 2005; 78(4): 805 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Herman and S. Moncada Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis Eur. Heart J., October 1, 2005; 26(19): 1945 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Royse and A. G. Royse The Myocardial and Vascular Effects of Bupivacaine, Levobupivacaine, and Ropivacaine Using Pressure Volume Loops Anesth. Analg., September 1, 2005; 101(3): 679 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Kodama, Y. Nishio, O. Sekine, Y. Sato, K. Egawa, H. Maegawa, and A. Kashiwagi Bidirectional regulation of monocyte chemoattractant protein-1 gene at distinct sites of its promoter by nitric oxide in vascular smooth muscle cells Am J Physiol Cell Physiol, September 1, 2005; 289(3): C582 - C590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Heller, E. Liu, A. M. Tager, S. Sinha, J. D. Roberts, S. L. Koehn, P. Libby, E. R. Aikawa, J. Q. Chen, P. Huang, et al. Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment Circulation, July 26, 2005; 112(4): 578 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dworschak, L. V. d'Uscio, D. Breukelmann, and J. D. Hannon Increased tolerance to hypoxic metabolic inhibition and reoxygenation of cardiomyocytes from apolipoprotein E-deficient mice Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H160 - H167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brownlee The Pathobiology of Diabetic Complications: A Unifying Mechanism Diabetes, June 1, 2005; 54(6): 1615 - 1625. [Full Text] [PDF]
|
|
|
|
|
|
X.-A. Li, L. Guo, J. L. Dressman, R. Asmis, and E. J. Smart A Novel Ligand-independent Apoptotic Pathway Induced by Scavenger Receptor Class B, Type I and Suppressed by Endothelial Nitric-oxide Synthase and High Density Lipoprotein J. Biol. Chem., May 13, 2005; 280(19): 19087 - 19096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Laufs, S. Wassmann, T. Czech, T. Munzel, M. Eisenhauer, M. Bohm, and G. Nickenig Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Lee, K.-M. Kim, S. Namkoong, C.-K. Kim, Y.-C. Kang, H. Lee, K.-S. Ha, J.-A Han, H.-T. Chung, Y.-G. Kwon, et al. Nitric Oxide Inhibition of Homocysteine-induced Human Endothelial Cell Apoptosis by Down-regulation of p53-dependent Noxa Expression through the Formation of S-Nitrosohomocysteine J. Biol. Chem., February 18, 2005; 280(7): 5781 - 5788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC Mouse Models of Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Ruiz-Feria, Y. Yang, and H. Nishimura Do incremental increases in blood pressure elicit neointimal plaques through endothelial injury? Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1486 - R1493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bhatia, K. Matsushita, M. Yamakuchi, C. N. Morrell, W. Cao, and C. J. Lowenstein Ceramide Triggers Weibel-Palade Body Exocytosis Circ. Res., August 6, 2004; 95(3): 319 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein, E. Stabile, T. Kinnaird, C. W. Lee, L. Clavijo, and M. S. Burnett Janus Phenomenon: The Interrelated Tradeoffs Inherent in Therapies Designed to Enhance Collateral Formation and Those Designed to Inhibit Atherogenesis Circulation, June 15, 2004; 109(23): 2826 - 2831. [Full Text] [PDF]
|
|
|
|
|
|
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Meir and E. Leitersdorf Atherosclerosis in the Apolipoprotein E-Deficient Mouse: A Decade of Progress Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1006 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Landmesser, B. Hornig, and H. Drexler Endothelial Function: A Critical Determinant in Atherosclerosis? Circulation, June 1, 2004; 109(21_suppl_1): II-27 - II-33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. SenBanerjee, Z. Lin, G. B. Atkins, D. M. Greif, R. M. Rao, A. Kumar, M. W. Feinberg, Z. Chen, D. I. Simon, F. W. Luscinskas, et al. KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation J. Exp. Med., May 17, 2004; 199(10): 1305 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Kuhlencordt, E. Rosel, R. E. Gerszten, M. Morales-Ruiz, D. Dombkowski, W. J. Atkinson, F. Han, F. Preffer, A. Rosenzweig, W. C. Sessa, et al. Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1195 - C1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Cooke Asymmetrical Dimethylarginine: The Uber Marker? Circulation, April 20, 2004; 109(15): 1813 - 1818. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Casas, L. E. Bautista, S. E. Humphries, and A. D. Hingorani Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease: Meta-Analysis of 26 Studies Involving 23028 Subjects Circulation, March 23, 2004; 109(11): 1359 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Daugherty and L. A. Cassis Mouse Models of Abdominal Aortic Aneurysms Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 429 - 434. [Abstract] [Full Text]
|
|
|
|
|
|
J. H. von der Thusen, M. L. Fekkes, R. Passier, A.J. van Zonneveld, V. Mainfroid, T. J.C. van Berkel, and E. A.L. Biessen Adenoviral Transfer of Endothelial Nitric Oxide Synthase Attenuates Lesion Formation in a Novel Murine Model of Postangioplasty Restenosis Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 357 - 362. [Abstract] [Full Text]
|
|
|
|
|
|
C. Kataoka, K. Egashira, M. Ishibashi, S. Inoue, W. Ni, K.-i. Hiasa, S. Kitamoto, M. Usui, and A. Takeshita Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H768 - H774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Sessa Atheroprotection in the Absence of "Caves": Is it the Fat, the Vessels, or Both? Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 4 - 6. [Full Text] [PDF]
|
|
|
|
|
|
R. Feil, S. M. Lohmann, H. de Jonge, U. Walter, and F. Hofmann Cyclic GMP-Dependent Protein Kinases and the Cardiovascular System: Insights From Genetically Modified Mice Circ. Res., November 14, 2003; 93(10): 907 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wolfsgruber, S. Feil, S. Brummer, O. Kuppinger, F. Hofmann, and R. Feil A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells PNAS, November 11, 2003; 100(23): 13519 - 13524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Grenache, T. Coleman, C. F. Semenkovich, S. A. Santoro, and M. M. Zutter {alpha}2{beta}1 Integrin and Development of Atherosclerosis in a Mouse Model: Assessment of Risk Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2104 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Khurana, Y. R. Sohni, W. I. Mangrum, R. L. McClelland, D. J. O'Kane, F. B. Meyer, and I. Meissner Endothelial Nitric Oxide Synthase T-786C Single Nucleotide Polymorphism: A Putative Genetic Marker Differentiating Small Versus Large Ruptured Intracranial Aneurysms Stroke, November 1, 2003; 34(11): 2555 - 2559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B Chesebro, E. Blessing, C.-C. Kuo, M. E Rosenfeld, M. Puolakkainen, and L. A. Campbell Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis Cardiovasc Res, October 15, 2003; 60(1): 170 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. van Haperen, C. Cheng, B. M. E. Mees, E. van Deel, M. de Waard, L. C.A. van Damme, T. van Gent, T. van Aken, R. Krams, D. J. Duncker, et al. Functional Expression of Endothelial Nitric Oxide Synthase Fused to Green Fluorescent Protein in Transgenic Mice Am. J. Pathol., October 1, 2003; 163(4): 1677 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, M. D. Brown, X. Wang, J. Wong, D. F. Kallmes, A. H. Matsumoto, G. A. Helm, T. A. Drake, and A. J. Lusis Genetic Backgrounds but Not Sizes of Atherosclerotic Lesions Determine Medial Destruction in the Aortic Root of Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1901 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lowson Nitric Oxide Signaling and Clinical Alternatives to Nitric Oxide Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 239 - 252. [Abstract] [PDF]
|
|
|
|
|
|
K. Saraff, F. Babamusta, L. A. Cassis, and A. Daugherty Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1621 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shiomi, T. Ito, S. Yamada, S. Kawashima, and J. Fan Development of an Animal Model for Spontaneous Myocardial Infarction (WHHLMI Rabbit) Arterioscler Thromb Vasc Biol, July 23, 2003; 23(7): 1239 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cullen, R. Baetta, S. Bellosta, F. Bernini, G. Chinetti, A. Cignarella, A. von Eckardstein, A. Exley, M. Goddard, M. Hofker, et al. Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist? Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 535 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W Shaul Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis J. Physiol., February 15, 2003; 547(1): 21 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yan, D. Kim, T. Aizawa, and B. C. Berk Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 26 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, P. Kuhlencordt, F. Urano, H. Ichinose, J. Astern, and P. L. Huang L-Arginine on Atherosclerosis in ApoE Knockout and ApoE/Inducible NO Synthase Double-Knockout Mice Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 97 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P B Massion and J-L Balligand Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice J. Physiol., January 1, 2003; 546(1): 63 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tateshima, Y. Murayama, J. P. Villablanca, T. Morino, K. Nomura, K. Tanishita, and F. Vinuela In Vitro Measurement of Fluid-Induced Wall Shear Stress in Unruptured Cerebral Aneurysms Harboring Blebs Stroke, January 1, 2003; 34(1): 187 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. van Haperen, M. de Waard, E. van Deel, B. Mees, M. Kutryk, T. van Aken, J. Hamming, F. Grosveld, D. J. Duncker, and R. de Crom Reduction of Blood Pressure, Plasma Cholesterol, and Atherosclerosis by Elevated Endothelial Nitric Oxide J. Biol. Chem., December 6, 2002; 277(50): 48803 - 48807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, C.-H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M. C. Fishman, P. L. Huang, and R. Weissleder In Vivo Imaging of Proteolytic Activity in Atherosclerosis Circulation, June 11, 2002; 105(23): 2766 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. M. Fedak, S. Verma, J. Butany, R. D. Weisel, and T. E. David Aortic valve malformations and pulmonary autograft root dilatation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1222 - 1223. [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, D. Dudley, and X. L. Wang Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency: Modifiable by Cigarette Smoking Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): e1 - 4. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W Manning, L. A Cassis, J. Huang, S. J Szilvassy, and A. Daugherty Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease Vascular Medicine, February 1, 2002; 7(1): 45 - 54. [Abstract] [PDF]
|
|
|
|
 |
|
 C. MINEO and P.W. SHAUL Modulation of Endothelial NO Production by High-density Lipoprotein Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 459 - 470. [Abstract] [PDF]
|
|
|
|
|
|
J. Chen, P. J. Kuhlencordt, J. Astern, R. Gyurko, and P. L. Huang Hypertension Does Not Account for the Accelerated Atherosclerosis and Development of Aneurysms in Male Apolipoprotein E/Endothelial Nitric Oxide Synthase Double Knockout Mice Circulation, November 13, 2001; 104(20): 2391 - 2394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, X. Wang, D. M. Shih, V. E. Laubach, M. Navab, and A. J. Lusis Paradoxical Reduction of Fatty Streak Formation in Mice Lacking Endothelial Nitric Oxide Synthase Circulation, April 30, 2002; 105(17): 2078 - 2082. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||